Free Trial
→ Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___ (From Behind the Markets) (Ad)tc pixel Free ORGO Stock Alerts

Organogenesis (ORGO) Short Interest Ratio & Short Volume

Organogenesis logo
$2.66 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$2.70 +0.04 (+1.50%)
As of 05/22/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Organogenesis Short Interest Overview

As of April 30, 2026, Organogenesis (ORGO) had a short interest of 15.86 million shares sold short, representing 18.39% of the public float. This marks a 21.04% increase in short interest since the prior report. The short interest ratio (days to cover) is 14.3, meaning it would take 14.3 days of the average trading volume of 1.56 million shares to cover all short positions.

Current Short Interest
15,855,307 shares
Previous Short Interest
13,098,705 shares
Change Vs. Previous Month
21.04%
Dollar Volume Sold Short
$37.26 million
Short Interest Ratio
14.3 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
128,680,000 shares
Short Percent of Float
18.39%
Today's Trading Volume
487,766 shares
Average Trading Volume
1,564,519 shares
Today's Volume Vs. Average
31%
Short Selling Organogenesis?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Organogenesis and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ORGO Short Interest Over Time

ORGO Days to Cover Over Time

ORGO Percentage of Float Shorted Over Time

Organogenesis Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202615,855,307 shares $37.26 million +21.0%18.4%14.26 $2.35
4/15/202613,098,705 shares $34.06 million +2.4%15.2%3.78 $2.60
3/31/202612,790,678 shares $30.31 million +1.6%14.8%23.73 $2.37
3/13/202612,589,968 shares $33.24 million -0.2%14.6%14.38 $2.64
2/27/202612,612,680 shares $40.49 million -3.5%14.6%20.36 $3.21
2/13/202613,072,172 shares $48.76 million +0.3%15.4%24.14 $3.73
1/30/202613,037,724 shares $52.15 million +1.1%15.3%20.65 $4.00
1/15/202612,892,111 shares $51.18 million -0.9%15.2%13.32 $3.97
12/31/202513,004,869 shares $67.37 million +15.4%15.3%7.93 $5.18
12/15/202511,267,548 shares $54.42 million +4.1%13.3%7.59 $4.83
11/28/202510,825,354 shares $52.29 million -0.5%12.7%7.25 $4.83
11/14/202510,880,975 shares $66.37 million +2.2%12.8%2.29 $6.10
10/31/202510,649,719 shares $45.26 million -4.2%12.5%15.61 $4.25
10/15/202511,110,000 shares $45.22 million +3.2%18.6%15.2 $4.07
9/30/202510,770,000 shares $45.45 million -0.8%18.2%13.3 $4.22
9/15/202510,860,000 shares $53.87 million +6.6%18.4%12.9 $4.96
8/31/202510,190,000 shares $52.48 million +4.0%17.2%11.6 $5.15
8/15/20259,800,000 shares $46.35 million +0.2%16.6%11.3 $4.73
7/31/20259,780,000 shares $45.18 million +0.5%15.3%8.6 $4.62
7/15/20259,730,000 shares $39.21 million -4.8%15.2%7.3 $4.03
6/30/202510,220,000 shares $37.41 million -5.5%15.9%7.4 $3.66
6/15/202510,810,000 shares $33.19 million -5.9%16.9%7.6 $3.07
5/31/202511,490,000 shares $31.83 million -5.0%17.8%7.8 $2.77
5/15/202512,100,000 shares $36.66 million +2.8%18.8%4.9 $3.03
4/30/202511,770,000 shares $57.79 million +15.3%18.3%5.1 $4.91
4/15/202510,210,000 shares $44.11 million +2.2%15.9%5.1 $4.32
3/31/20259,990,000 shares $43.16 million +15.9%15.5%5.6 $4.32
3/15/20258,620,000 shares $43.19 million No Change13.4%5.1 $5.01
2/28/20258,620,000 shares $53.63 million -0.6%13.4%5.3 $6.22
2/15/20258,670,000 shares $32.08 million -0.9%13.2%13.6 $3.70
1/31/20258,750,000 shares $32.20 million -16.0%13.4%12.1 $3.68
1/15/202510,420,000 shares $33.66 million +0.2%16.2%14.5 $3.23
12/31/202410,400,000 shares $33.28 million -5.5%15.4%14.4 $3.20
12/15/202411,000,000 shares $37.40 million +29.1%16.3%15.9 $3.40
11/30/20248,520,000 shares $32.97 million -18.2%11.9%13 $3.87
11/15/202410,410,000 shares $40.18 million +6.3%13.7%19.6 $3.86
10/31/20249,790,000 shares $27.12 million -5.0%12.6%18.3 $2.77
10/15/202410,300,000 shares $32.96 million -1.3%13.3%18.3 $3.20
9/30/202410,440,000 shares $29.86 million -10.6%13.4%16.9 $2.86
9/15/202411,680,000 shares $32.82 million -16.5%15.0%16.1 $2.81
One page of the SpaceX S-1 will move this stock overnight (Ad)

When SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including power consumption for 1 million GPUs, a cost that rivals entire cities. That disclosure will name the supplier. One small, publicly traded power infrastructure company sits at the center of this - carrying a $1.5 billion backlog and priced like a utility. Dylan Jovine has the full breakdown.tc pixel

See the stock the S-1 revealed >>
8/31/202413,990,000 shares $40.29 million +28.0%18.0%17.2 $2.88
8/15/202410,930,000 shares $27.54 million +10.4%14.1%11.2 $2.52
7/31/20249,900,000 shares $29.90 million +2.0%12.7%9.7 $3.02
7/15/20249,710,000 shares $28.06 million -14.3%12.5%8 $2.89
6/30/202411,330,000 shares $31.72 million +3.8%14.6%9.4 $2.80
6/15/202410,920,000 shares $27.25 million +1.8%14.0%8.9 $2.50
5/31/202410,730,000 shares $29.51 million -5.3%13.8%9.2 $2.75
5/15/202411,330,000 shares $33.65 million +16.3%14.6%10.7 $2.97
4/30/20249,740,000 shares $22.89 million +17.1%12.6%10.2 $2.35
4/15/20248,320,000 shares $22.96 million +15.1%10.8%10.7 $2.76
3/31/20247,230,000 shares $20.53 million -9.7%9.4%9.4 $2.84
3/15/20248,010,000 shares $22.83 million +5.8%10.3%11.5 $2.85
2/29/20247,570,000 shares $27.02 million +1.3%9.8%9.9 $3.57
2/15/20247,470,000 shares $27.49 million +11.3%9.4%10.2 $3.68
1/31/20246,710,000 shares $22.14 million +4.2%8.5%6.9 $3.30
1/15/20246,440,000 shares $25.24 million +56.7%8.2%6.6 $3.92
12/31/20234,110,000 shares $16.81 million -15.4%5.2%4.3 $4.09
12/15/20234,860,000 shares $18.23 million +4.1%6.2%5 $3.75
11/30/20234,670,000 shares $11.91 million -0.4%6.0%5.1 $2.55
11/15/20234,690,000 shares $11.87 million -1.7%6.0%5.4 $2.53
10/31/20234,770,000 shares $10.68 million +12.8%6.1%5 $2.24
10/15/20234,230,000 shares $9.98 million +8.2%5.4%5.1 $2.36
9/30/20233,910,000 shares $12.43 million +1.6%5.0%4.4 $3.18
9/15/20233,850,000 shares $9.43 million +25.8%4.9%4.5 $2.45
8/31/20233,060,000 shares $8.57 million +8.1%3.9%3.4 $2.80
8/15/20232,830,000 shares $7.58 million -16.5%3.6%2.8 $2.68
7/31/20233,390,000 shares $14.48 million -0.6%4.4%3.1 $4.27
7/15/20233,410,000 shares $13.30 million -7.3%5.1%3.2 $3.90
6/30/20233,680,000 shares $12.22 million -7.5%5.5%3.7 $3.32
6/15/20233,980,000 shares $16.36 million -14.0%5.9%3.8 $4.11
5/31/20234,630,000 shares $16.81 million -10.1%6.9%3.2 $3.63
5/15/20235,150,000 shares $16.38 million +0.8%7.7%3.5 $3.18
4/30/20235,110,000 shares $10.48 million +0.2%7.6%4 $2.05
4/15/20235,100,000 shares $10.56 million -1.5%7.6%4.1 $2.07
3/31/20235,180,000 shares $11.03 million -35.8%7.7%4.1 $2.13
3/15/20238,070,000 shares $17.43 million +1.3%12.1%6.5 $2.16
2/28/20237,970,000 shares $19.53 million +12.4%11.9%10 $2.45
2/15/20237,090,000 shares $20.70 million +12.2%10.2%10.7 $2.92
1/31/20236,320,000 shares $16.18 million +9.9%9.2%9.4 $2.56
1/15/20235,750,000 shares $14.89 million +2.0%8.4%9.2 $2.59
12/30/20225,640,000 shares $15.17 million +14.6%8.2%9.3 $2.69
12/15/20224,920,000 shares $12.50 million +4.9%7.8%8.1 $2.54
11/30/20224,690,000 shares $12.85 million -20.9%7.4%6.4 $2.74
11/15/20225,930,000 shares $17.02 million -0.7%9.3%6.9 $2.87
10/31/20225,970,000 shares $19.58 million +5.1%9.4%6.4 $3.28
10/15/20225,680,000 shares $18.18 million -1.1%9.0%5.7 $3.20
9/30/20225,740,000 shares $18.60 million -17.5%9.0%5.3 $3.24
9/15/20226,960,000 shares $24.78 million +7.4%11.0%5.9 $3.56
8/31/20226,480,000 shares $23.26 million +4.5%10.4%5.8 $3.59
8/15/20226,200,000 shares $30.19 million -16.9%9.9%5.8 $4.87
You cannot escape this reality (Ad)

The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.tc pixel

Read Porter Stansberry's full briefing and find out which moves to make now
7/31/20227,460,000 shares $42.82 million +2.1%12.1%6.8 $5.74
7/15/20227,310,000 shares $38.52 million +6.7%11.8%6.8 $5.27
6/30/20226,850,000 shares $33.43 million -3.3%11.1%6.3 $4.88
6/15/20227,080,000 shares $36.75 million -2.5%11.4%6.8 $5.19
5/31/20227,260,000 shares $40.73 million -12.6%11.7%6.7 $5.61
5/15/20228,310,000 shares $51.27 million -13.4%13.4%7.2 $6.17
4/30/20229,600,000 shares $61.82 million +9.2%15.6%8.6 $6.44
4/15/20228,790,000 shares $64.61 million +10.7%14.2%8.1 $7.35
3/31/20227,940,000 shares $60.50 million -5.4%12.9%7.4 $7.62
3/15/20228,390,000 shares $62.51 million -10.9%13.6%8.1 $7.45
2/28/20229,420,000 shares $70.08 million -8.5%15.3%9.5 $7.44
2/15/202210,300,000 shares $82.71 million +24.7%16.5%11.4 $8.03
1/31/20228,260,000 shares $63.52 million +0.9%17.8%9.7 $7.69
1/15/20228,190,000 shares $68.96 million -4.4%15.0%9.8 $8.42
12/31/20218,570,000 shares $79.19 million +15.8%15.7%8.9 $9.24
12/15/20217,400,000 shares $67.41 million +0.4%13.4%7 $9.11
11/30/20217,370,000 shares $74.14 million -1.7%13.3%6.6 $10.06
11/15/20217,500,000 shares $81 million -18.0%11.9%6.6 $10.80
10/29/20219,150,000 shares $100.47 million +17.0%14.6%8.3 $10.98
10/15/20217,820,000 shares $85.63 million +28.2%12.4%7.3 $10.95
9/30/20216,100,000 shares $59.54 million +4.5%9.8%6.6 $9.76
9/15/20215,840,000 shares $90.46 million -6.0%9.3%6.1 $15.49
8/31/20216,210,000 shares $105.94 million -4.9%9.9%6.4 $17.06
8/13/20216,530,000 shares $98.54 million -2.4%10.5%4.9 $15.09
7/30/20216,690,000 shares $102.62 million +3.1%10.8%4.8 $15.34
7/15/20216,490,000 shares $102.35 million +0.3%10.4%4.8 $15.77
6/30/20216,470,000 shares $107.53 million +70.7%10.3%4.9 $16.62
6/15/20213,790,000 shares $59.84 million +14.2%6.0%2.9 $15.79
5/28/20213,320,000 shares $59.20 million +32.8%5.3%2.9 $17.83

ORGO Short Interest - Frequently Asked Questions

Short interest is the volume of Organogenesis shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 15,855,307 shares of ORGO short. 18.39% of Organogenesis' shares are currently sold short. Learn More on Organogenesis' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGO shares currently have a short interest ratio of 14.3. Learn More on Organogenesis's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.39% of Organogenesis' floating shares are currently sold short.

Organogenesis saw a increase in short interest in April. As of April 30th, there was short interest totaling 15,855,307 shares, an increase of 21.0% from the previous total of 13,098,705 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.39% of Organogenesis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Organogenesis: Maplight Therapeutics, Inc. (4.26%), Septerna, Inc. (4.81%), Olema Pharmaceuticals, Inc. (17.08%), DBV Technologies S.A. (3.31%), Harrow, Inc. (19.93%), Jade Biosciences, Inc. (8.15%), Collegium Pharmaceutical, Inc. (18.65%), Xeris Biopharma Holdings, Inc. (9.65%), Maravai LifeSciences Holdings, Inc. (3.54%), Aktis Oncology (4.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ORGO is an investing strategy that aims to generate trading profit from Organogenesis as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Organogenesis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGO, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ORGO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ORGO) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel